Osteoprotegerin serum levels in primary hyperparathyroidism and changes following surgery

Horm Metab Res. 2014 May;46(5):375. doi: 10.1055/s-0033-1363278. Epub 2014 Jan 10.

Authors

S Minisola¹, C Cipriani¹, S Piemonte¹, L Colangelo¹, J Pepe¹, E Romagnoli¹

Affiliation

¹ Department of Internal Medicine and Medical Disciplines, "Sapienza" Rome University, Rome, Italy.

PMID: 24415533
DOI: 10.1055/s-0033-1363278

No abstract available

Publication types

Letter
Comment

MeSH terms

Alendronate / therapeutic use*
Bone Density Conservation Agents / therapeutic use*
Bone Remodeling*
Female
Humans
Hyperparathyroidism, Primary / therapy*
Male
Osteoprotegerin / blood*
RANK Ligand / blood*

Substances

Bone Density Conservation Agents
Osteoprotegerin
RANK Ligand
Alendronate